Evidence map›Paper›PMID 42188796›Full record

ArticleVaccines2026

Incidence of COVID-19 and Influenza-Related Outcomes and Vaccinations in the United States, October 2022 Through December 2024.

Heather R Hensler, Tianyi Lu, Yoonyoung Park, Machaon Bonafede, Isabelle Winer, Christopher Adams, Keya Joshi, Amanda Wilson

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Heather R HenslerModerna, Inc., Cambridge, MA 02142, USA.
Tianyi LuModerna, Inc., Cambridge, MA 02142, USA.
Yoonyoung ParkModerna, Inc., Cambridge, MA 02142, USA.
Machaon BonafedeVeradigm, Chicago, IL 60654, USA.
Isabelle WinerVeradigm, Chicago, IL 60654, USA.ORCID 0000-0002-7294-8162
Christopher AdamsVeradigm, Chicago, IL 60654, USA.
Keya JoshiModerna, Inc., Cambridge, MA 02142, USA.
Amanda WilsonModerna, Inc., Cambridge, MA 02142, USA.

Funding

Moderna Therapeutics (United States) N/A
6 · The paper itself

Abstract

BACKGROUND/

objectivesWe still do not clearly know whether COVID-19 continues to impose a greater clinical burden than influenza in the "post-pandemic" era. Our study quantified and compared monthly COVID-19 and influenza hospitalization incidence among adult subgroups from October 2022 through December 2024. We assessed vaccine coverage trends and examined vaccination status among those hospitalized.

methodsUsing the Veradigm linked claims and electronic health record dataset, we conducted a non-interventional, retrospective cohort study; three monthly cohorts included individuals aged 65+, high-risk (HR) adults (defined as adults 18+ with HR conditions and/or aged 65+), and adults aged 50-64 years who were enrolled with both medical and pharmacy coverage. We estimated monthly cumulative incidence of COVID-19 and influenza-related hospitalizations, vaccination coverage rates, and the proportion of hospitalized individuals who had received yearly updated vaccines.

resultsCOVID-19 hospitalizations consistently exceeded those of influenza across months and populations. Among adults aged 65+, COVID-19 hospitalization rates were 2-3 times higher than influenza in winter and 20-30 times higher during off-season months, with similar trends observed in high risk adults. COVID-19 incidence surged in summer, while influenza remained seasonally confined. Vaccination coverage for influenza peaked near 50% annually; COVID-19 coverage was lower, peaking at ~26% by December each year. Most hospitalizations occurred among unvaccinated individuals, particularly for COVID-19.

conclusionsCOVID-19 continues to impose a substantial, year-round burden, particularly in older and high-risk adults, exceeding that of influenza. The high proportion of unvaccinated hospitalizations highlight a critical gap in prevention efforts and underscore the need for improved public health messaging and vaccine adoption.

Indexed as

COVID-19hospitalizationinfluenzamRNA vaccinesreal-world evidencevaccination

Identifiers

PMID42188796
PMCPMC13211418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.